Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma

Daud, Adil; Soon, Christopher; Dummer, Reinhard; Eggermont, Alexander M. M.; Hwu, Wen-Jen; Grob, Jean Jacques; Garbe, Claus; Hauschild, Axel

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2014-03-18T09:45:19Z
dc.date.available	2014-03-18T09:45:19Z
dc.date.issued	2012
dc.identifier.issn	1471-2598
dc.identifier.uri	http://hdl.handle.net/10900/45953
dc.language.iso	en	de_DE
dc.publisher	Informa Healthcare	de_DE
dc.relation.uri	http://dx.doi.org/10.1517/14712598.2012.694421	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01581	de_DE
utue.publikation.seiten	1087-1099	de_DE
utue.personen.roh	Daud, Adil
utue.personen.roh	Soon, Christopher
utue.personen.roh	Dummer, Reinhard
utue.personen.roh	Eggermont, Alexander M. M.
utue.personen.roh	Hwu, Wen-Jen
utue.personen.roh	Grob, Jean Jacques
utue.personen.roh	Garbe, Claus
utue.personen.roh	Hauschild, Axel
dcterms.isPartOf.ZSTitelID	Expert Opinion on Biological Therapy	de_DE
dcterms.isPartOf.ZS-Issue	8	de_DE
dcterms.isPartOf.ZS-Volume	12	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE